Бюллетень экспериментальной биологии и медицины\r\nКлеточные технологии в биологии и медицине. Том 153. 2012. С. 825-827
The study demonstrated possible design of a medicinal formulation in the form of suppositories comprising human recombinant interferon-α2 and dry aloe extract. The approaches to the development of the suppositories were technology - derived. No interaction between the active and auxiliary components was proved by solid state 1H-NMR spectroscopy. The specific activity of the drug was investigated.